Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
28 May 2004 04:36 PM
RNS
Holding(s) in Company
27 May 2004 07:00 AM
RNS
Pioneering Research
21 May 2004 09:17 AM
RNS
Blocklisting Interim Review
12 May 2004 04:42 PM
RNS
Holding(s) in Company
12 May 2004 04:16 PM
RNS
Directorate Change
29 Apr 2004 07:00 AM
RNS
Regulatory Approval
20 Apr 2004 12:10 PM
RNS
AGM Statement
29 Mar 2004 07:00 AM
RNS
Research Update
03 Mar 2004 07:00 AM
RNS
Final Results
20 Feb 2004 02:50 PM
RNS
Holding(s) in Company
05 Feb 2004 08:30 AM
RNS
LentiVector Update
21 Jan 2004 07:00 AM
RNS
Notice of Results
16 Jan 2004 07:00 AM
RNS
Update on TroVax
18 Dec 2003 07:00 AM
RNS
Research Update
15 Dec 2003 07:33 AM
RNS
Product Update
01 Dec 2003 10:56 AM
RNS
Holding(s) in Company
27 Nov 2003 07:00 AM
RNS
Research Update
24 Nov 2003 09:12 AM
RNS
Blocklisting Interim Review
13 Nov 2003 07:00 AM
RNS
Preclinical update
10 Nov 2003 05:53 PM
RNS
Holding(s) in Company
05 Nov 2003 08:37 AM
RNS
Holding(s) in Company
05 Nov 2003 08:29 AM
RNS
Holding(s) in Company
29 Oct 2003 04:25 PM
RNS
Holding(s) in Company
27 Oct 2003 05:29 PM
RNS
Result of Equity Issue
24 Oct 2003 09:51 AM
RNS
Research Update
23 Oct 2003 08:47 AM
RNS
Director Shareholding
02 Oct 2003 01:10 PM
RNS
Result of EGM
16 Sep 2003 07:01 AM
RNS
Rights Issue
16 Sep 2003 07:00 AM
RNS
Interim Results
09 Sep 2003 07:00 AM
RNS
Retinostat Agreement
28 Aug 2003 07:00 AM
RNS
Re Joint Venture
20 Aug 2003 07:00 AM
RNS
Notice of Results
13 Aug 2003 07:00 AM
RNS
LentiVector Patent Update
14 Jul 2003 07:00 AM
RNS
TroVax Update
03 Jul 2003 07:00 AM
RNS
Research Update
23 Jun 2003 07:00 AM
RNS
Update on ProSavin
27 May 2003 03:25 PM
RNS
Blocklisting Interim Review
22 May 2003 10:16 AM
RNS
Additional Listing
20 May 2003 07:00 AM
RNS
TroVax Update
06 May 2003 07:00 AM
RNS
Data on RetinoStat
23 Apr 2003 02:43 PM
RNS
Holding(s) in Company
15 Apr 2003 07:00 AM
RNS
AGM Statement
18 Mar 2003 07:00 AM
RNS
Option Agreement
04 Mar 2003 07:00 AM
RNS
Wyeth Collaboration Update
04 Mar 2003 07:00 AM
RNS
Final Results
03 Mar 2003 07:00 AM
RNS
TroVax to Enter Phase II
12 Feb 2003 09:09 AM
RNS
Notice of Results
11 Feb 2003 07:00 AM
RNS
Grant Awarded
28 Jan 2003 07:00 AM
RNS
Joint Programme Agreed
20 Jan 2003 04:01 PM
RNS
Holding(s) in Company

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100

Latest directors dealings